Indication
Colorectal cancer
Colorectal cancer is a malignant neoplasm originating from the epithelial lining of the large intestine, encompassing either the colon or the rectum. Read more about Colorectal cancer
17 drugs 17 manufacturers
Drugs that treat it
Common Colorectal cancer therapies.
ADRUCIL (fluorouracil)
ADRUCIL (fluorouracil)
FLUOROURACIL
FLUOROURACIL
FLUOROURACIL
FLUOROURACIL
FLUOROURACIL
FLUOROURACIL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonColorectal cancer is a malignant neoplasm originating from the epithelial lining of the large intestine, encompassing either the colon or the rectum.
It predominantly develops in older adults, though it also occurs in younger populations, through the gradual malignant transformation of precancerous adenomatous or serrated polyps driven by progressive genetic and epigenetic alterations.
Pathologically, the vast majority of cases are adenocarcinomas that arise in the glandular epithelium of the intestinal mucosa.
Defining clinical features often include occult or overt gastrointestinal bleeding, persistent alterations in bowel habits, iron deficiency anemia, abdominal discomfort, and intestinal obstruction in advanced or metastatic stages.
- cancer.gov
Colorectal cancer is a malignant neoplasm originating from the epithelial lining of the large intestine, encompassing either the colon or the rectum
- nih.gov
Colorectal cancer is a malignant neoplasm originating from the epithelial lining of the large intestine, encompassing either the colon or the rectum It predominantly develops in older adults, though it also occurs in younger populations, through the gradual malignant transformation of precancerous adenomatous or serrated polyps driven by progressive genetic and epigenetic alterations
- cdc.gov
It predominantly develops in older adults, though it also occurs in younger populations, through the gradual malignant transformation of precancerous adenomatous or serrated polyps driven by progressive genetic and epigenetic alterations
- fda.gov
It predominantly develops in older adults, though it also occurs in younger populations, through the gradual malignant transformation of precancerous adenomatous or serrated polyps driven by progressive genetic and epigenetic alterations Defining clinical features often include occult or overt gastrointestinal bleeding, persistent alterations in bowel habits, iron deficiency anemia, abdominal discomfort, and intestinal obstruction in advanced or metastatic stages
- cancer.gov
Pathologically, the vast majority of cases are adenocarcinomas that arise in the glandular epithelium of the intestinal mucosa
- who.int
Defining clinical features often include occult or overt gastrointestinal bleeding, persistent alterations in bowel habits, iron deficiency anemia, abdominal discomfort, and intestinal obstruction in advanced or metastatic stages
Personalize your experience
Follow Colorectal cancer and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.